Article
CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype.
Journal for immunotherapy of cancer - 20 Nov 2023
Lee Sang Yun, Lee Dong Hoon, Sun Wei, Cervantes-Contreras Francisco, Basom Ryan S, Wu Feinan, Liu Si, Rai Richa, Mirzaei Hamid R, O'Steen Shyril, Green Damian J, Shadman Mazyar, Till Brian G
Abstract excerpt
BACKGROUND: Cell culture conditions during manufacturing can impact the clinical efficacy of chimeric antigen receptor (CAR) T cell products. Production methods have not been standardized because the optimal approach remains unknown. Separate CD4+ and CD8+ cultures offer a potential advantage but complicate manufacturing and may affect cell expansion and function. In a phase 1/2 clinical trial, we observed poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
